Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of remimazolam on autonomic circulatory control function
jRCT1031240189Completed
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam (2 arms). Primary endpoint: Spontaneous fluctuation waveforms of heart rate and blood pressure. Started Jun 2024; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on jRCT1031240189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031240189.